Background {#Sec1}
==========

Andrology is the medical specialty that focuses on many aspects of male health, comprising a wide range of conditions of the male reproductive system, as well as urological pathologies that are specific to men. Although the clinical science had been studied for many years, it was not until after the introduction of the term 'andrology' in 1951 that scientists and clinicians from a diverse range of backgrounds began to refer to themselves as 'andrologists' \[[@CR1]\]. Since then the discipline has continued to evolve, with the introduction of national and international societies, recognised and accredited training courses and a number of high quality dedicated journals. In the present day, andrologists are involved in the management of a wide spectrum of diseases ranging from male factor infertility through to hypogonadism and penile cancer. As the specialty grows and the body of literature focusing on andrological topics expands it is important to establish the most important and influential manuscripts that have shaped, and continue to shape, current research and clinical practice.

The generation of a citation rank list is one method of identifying the published material within a given field that has greatest intellectual influence \[[@CR2]\]. A citation refers to the referencing of an article by another peer-reviewed publication. It is therefore probable that articles which have the greatest impact on the scientific and clinical communities are cited many times more than those which have had little impact. Citation analysis is the process of ranking the most frequently cited articles in order to produce a citation rank list. In addition, citation numbers can be used to rank journals through calculation of their 'impact factor.' This is a measure of the average number of citations a manuscript published in a particular journal received during a specific timeframe and is often used a surrogate marker for journal quality.

A number of clinical disciplines have employed citation analysis to determine the most influential articles in their field. These include entire specialties such as general surgery \[[@CR3]\], plastic surgery \[[@CR4]\] and orthopaedic surgery \[[@CR5]\], as well as subspecialties such as laparoscopic and emergency abdominal surgery \[[@CR6], [@CR7]\]. Whilst citation analysis has been conducted within urology as a whole \[[@CR8], [@CR9]\], and more specifically for male factor infertility \[[@CR10]\], no study to date has been undertaken to determine the most influential manuscripts in andrology. This bibliometric analysis therefore aimed to identify the most influential articles in the field, as well as key research themes that have been instrumental in developing our contemporary understanding and management of andrological conditions.

Methods {#Sec2}
=======

The Thompson Reuters Web of Science citation indexing database was interrogated using the method previously described by Ellul et al. \[[@CR6]\]. As andrology is a broad subspecialty that draws from a range of other disciplines, it is probable that influential articles pertaining to relevant topics have been published in a wide array of journals, not just those specific to urology and sexual medicine. A number of title search terms were therefore selected and combined to ensure all relevant manuscripts were identified, as follows: 'andrology', 'male infertility', 'erectile dysfunction', 'impotence', 'penile deformity', 'penile curvature', 'peyronie's disease', 'priapism', 'penile fracture', 'ejaculatory disorder', 'male sexual dysfunction', 'hypogonadism', 'penile cancer', 'squamous cell carcinoma' and 'penis'. Truncation using the asterisk function (\*) was utilised for particular words with multiple relevant variations, for example the term 'peni\*' was used to capture both 'penis' and 'penile'. These search terms were chosen to reflect the core topics published in the European Academy of Andrology-European Society of Andrological Urology Joint Educational Curriculum for Clinical Andrology Training in Europe \[[@CR11]\].

The search was conducted on 5th June 2018 and included all manuscripts published in the English language from 1900 onwards. Results were subsequently ranked by citation number. Final interrogation of the database was independently performed by two assessors (NB and TE). The 100 most cited articles were further evaluated according to subject, first and senior author, journal, year of publication, institution and country of origin. The 2016 impact factor of each journal was also identified from the Journal Citation Reports dataset \[[@CR12]\]. In order to adjust for older articles accruing a higher number of citations over time the citation rate was calculated by dividing the number of citations by the number of years since publication. Articles were excluded if published prior to 1900, in languages other than English and/or if, after independent assessment by two researchers, it was agreed the main focus was not directly relevant to the field andrology. In cases of disagreement on the suitability for inclusion, the manuscript in question was discussed by both assessors and a consensus decision reached.

Results {#Sec3}
=======

The Web of Science search returned a total of 24,128 manuscripts. Table [1](#Tab1){ref-type="table"} lists the 100 most cited articles as ranked by citation number, following application of exclusion criteria. Where two articles had equal numbers of citations, further stratification was based on citation rate. The most cited article was that by Feldman et al. describing the prevalence of and risk factors for erectile dysfunction (ED) in the Massachusetts Male Ageing Study, published in The Journal of Urology in 1994 and has been cited 2819 times \[[@CR13]\].Table 1The 100 most cited manuscripts in AndrologyRankManuscript (first author, title, journal and year)Citations1Feldman HA. Impotence and its medical and psychosocial correlates - results of the Massachusetts male aging study. Journal of Urology 1994.28192Rosen RC. The international index of erectile function (IIEF): A multidimensional scale for assessment of erectile dysfunction. Urology 1997.24803Goldstein I. Oral sildenafil in the treatment of erectile dysfunction. New England Journal of Medicine 1998.15154Rosen RC. Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. International Journal of Impotence Research 1999.13255Droller MJ. Impotence: NIH consensus development panel on impotence. Journal of the American Medical Association 1993.12706de Roux N. Hypogonadotropic hypogonadism due to loss of function of the KiSS1-derived peptide receptor GPR54. Proceedings of the National Academy of Sciences of the United States of America 2003.12377Walsh PC. Impotence following radical prostatectomy - insight into etiology and prevention. Journal of Urology 1982.10448Lue TF. Drug therapy: Erectile dysfunction. New England Journal of Medicine 2000.7939Rosen R. Lower urinary tract symptoms and male sexual dysfunction: The multinational survey of the aging male (MSAM-7). European Urology 2003.67510Evenson DP. Sperm chromatin structure assay: Its clinical use for detecting sperm DNA fragmentation in male infertility and comparisons with other techniques. Journal of Andrology 2002.61011Eddy EM. Targeted disruption of the estrogen receptor gene in male mice causes alteration of spermatogenesis and infertility. Endocrinology 1996.60712Johannes CB. Incidence of erectile dysfunction in men 40 to 69 years old: Longitudinal results from the Massachusetts male aging study. Journal of Urology 2000.55813Aytac IA. The likely worldwide increase in erectile dysfunction between 1995 and 2025 and some possible policy consequences. British Journal of Urology International 1999.55314Muscatelli F. Mutations in the dax-1 gene give rise to both x-linked adrenal hypoplasia congenita and hypogonadotropic hypogonadism. Nature 1994.53615Wu FCW. Identification of Late-Onset Hypogonadism in Middle-Aged and Elderly Men. New England Journal of Medicine 2010.52416Katznelson L. Increase in bone density and lean body mass during testosterone administration in men with acquired hypogonadism. Journal of Clinical Endocrinology & Metabolism 1996.51617Sharma RK. Role of reactive oxygen species in male infertility. Urology 1996.51618Braun M. Epidemiology of erectile dysfunction: results of the 'Cologne Male Survey'. International Journal of Impotence Research 2000.51119Mason AJ. A deletion truncating the gonadotropin-releasing-hormone gene is responsible for hypogonadism in the hpg mouse. Science 1986.49220Krane RJ. Impotence. New England Journal of Medicine 1989.48221Thompson IM. Erectile dysfunction and subsequent cardiovascular disease. Journal of the American Medical Association 2005.*481*22Tremellen K. Oxidative stress and male infertility-a clinical perspective. Human Reproduction Update 2008.47923Lue TF. Physiology of erection and pharmacological management of impotence. Journal of Urology 1987.45824Cattanach BM. Gonadotrophin-releasing hormone deficiency in a mutant mouse with hypogonadism. Nature 1977.45325de Tejada IS. Impaired neurogenic and endothelium-mediated relaxation of penile smooth-muscle from diabetic men with impotence. New England Journal of Medicine 1989.43826Esposito K. Effect of lifestyle changes on erectile dysfunction in obese men - A randomized controlled trial. Journal of the American Medical Association 2004.43427Feldman HA. Erectile dysfunction and coronary risk factors: Prospective results from the Massachusetts Male Aging Study. Preventive Medicine 2000.43128Boolell M. Sildenafil, a novel effective oral therapy for male erectile dysfunction. British Journal of Urology 1996.42329Terrett NK. Sildenafil (VIAGRA), a potent and selective inhibitor of type 5 cGMP phosphodiesterase with utility for the treatment of male erectile dysfunction. Bioorganic & Medicinal Chemistry Letters 1996.42130Thorner MO. Long-term treatment of galactorrhea and hypogonadism with bromocriptine. British Medical Journal 1974.42131Hatzimouratidis K. Guidelines on Male Sexual Dysfunction: Erectile Dysfunction and Premature Ejaculation. European Urology 2010.42032Dubin L. Etiologic factors in 1294 consecutive cases of male infertility. Fertility and Sterility 1971.41833Rendell MS. Sildenafil for treatment of erectile dysfunction in men with diabetes - A randomized controlled trial. Journal of the American Medical Association 1999.41734Tut TG. Long polyglutamine tracts in the androgen receptor are associated with reduced trans-activation, impaired sperm production, and male infertility. Journal of Clinical Endocrinology & Metabolism 1997.41635Carter JN. Prolactin-secreting tumors and hypogonadism in 22 men. New England Journal of Medicine 1978.41436Whorton D. Infertility in male pesticide workers. Lancet 1977.40537Topaloglu AK. TAC3 and TACR3 mutations in familial hypogonadotropic hypogonadism reveal a key role for Neurokinin B in the central control of reproduction. Nature Genetics 2009.39538Dix DJ. Targeted gene disruption of Hsp70--2 results in failed meiosis, germ cell apoptosis, and male infertility. Proceedings of the National Academy of Sciences of the United States of America 1996.39339Agarwal A. Role of sperm chromatin abnormalities and DNA damage in male infertility. Human Reproduction Update 2003.38940Brindley GS. Cavernosal alpha-blockade - a new technique for investigating and treating erectile impotence. British Journal of Psychiatry 1983.37441Padma-Nathan H. Treatment of men with erectile dysfunction with transurethral alprostadil. New England Journal of Medicine 1997.35442Morales A. Clinical safety of oral sildenafil citrate (VIAGRA) in the treatment of erectile dysfunction. International Journal of Impotence Research 1998.35143Virag R. Is impotence an arterial disorder - a study of arterial risk-factors in 440 impotent men. Lancet 1985.34944Araujo AB. The relationship between depressive symptoms and male erectile dysfunction: Cross-sectional results from the Massachusetts Male Aging Study. Psychosomatic Medicine 1998.34545Montorsi F. Erectile dysfunction prevalence, time of onset and association with risk factors in 300 consecutive patients with acute chest pain and angiographically documented coronary artery disease. European Urology 2003.34046Mulligan T. Prevalence of hypogonadism in males aged at least 45 years: the HIM study. International Journal of Clinical Practice 2006.33147Oliva R. Protamines and male infertility. Human Reproduction Update 2006.33048Brock GB. Efficacy and safety of tadalafil for the treatment of erectile dysfunction: Results of integrated analyses. Journal of Urology 2002.33049Dhindsa S. Frequent occurrence of hypogonadotropic hypogonadism in type 2 diabetes. Journal of Clinical Endocrinology & Metabolism 2004.32750Roth JC. FSH and LH response to luteinizing hormone-releasing factor in prepubertal and pubertal children, adult males and patients with hypogonadotropic and hypergonadotropic hypogonadism. Journal of Clinical Endocrinology & Metabolism 1972.32151Zorgniotti AW. Auto-injection of the corpus cavernosum with a vasoactive drug-combination for vasculogenic impotence. Journal of Urology 1985.31952de Roux N. A family with hypogonadotropic hypogonadism and mutations in the gonadotropin-releasing hormone receptor. New England Journal of Medicine 1997.31453Martin-Morales A. Prevalence and independent risk factors for erectile dysfunction in Spain: Results of the Epidemiologia de la Disfuncion Erectil Masculina study. Journal of Urology 2001.30854Saleh RA. Oxidative stress and male infertility: From research bench to clinical practice. Journal of Andrology 2002.30755Derby CA. Modifiable risk factors and erectile dysfunction: Can lifestyle changes modify risk? Urology 2000.30156Linet OI. Efficacy and safety of intracavernosal alprostadil in men with erectile dysfunction. New England Journal of Medicine 1996.30057Agarwal A. Clinical relevance of oxidative stress in male factor infertility: An update. American Journal of Reproductive Immunology 2008.29958Lue TF. Vasculogenic impotence evaluated by high-resolution ultrasonography and pulsed doppler spectrum analysis. Radiology 1985.29859Rosen RC. The multinational Men's Attitudes to Life Events and Sexuality (MALES) study: I. Prevalence of erectile dysfunction and related health concerns in the general population. Current Medical Research and Opinion 2004.29760Finkelstein JS. Osteoporosis in men with idiopathic hypogonadotropic hypogonadism. Annals of Internal Medicine 1987.29561Kodama H. Increased oxidative deoxyribonucleic acid damage in the spermatozoa of infertile male patients. Fertility and Sterility 1997.29362Lapatto R. Kiss1(−/−) mice exhibit more variable hypogonadism than Gpr54(−/−) mice. Endocrinology 2007.29163Smith JC. The effects of induced hypogonadism on arterial stiffness, body composition, and metabolic parameters in males with prostate cancer. Journal of Clinical Endocrinology & Metabolism 2001.28864McCulloch DK. The prevalence of diabetic impotence. Diabetologia 1980.28765Debraekeleer M. Cytogenetic studies in male-infertility - a review. Human Reproduction 1991.27766Selvin E. Prevalence and risk factors for erectile dysfunction in the US. American Journal of Medicine 2007.27667Mulryan K. Reduced vas deferens contraction and male infertility in mice lacking P2X(1) receptors. Nature 2000.27568Solomon H. Erectile dysfunction and the cardiovascular patient: endothelial dysfunction is the common denominator. Heart 2003.27069Hendren SK. Prevalence of male and female sexual dysfunction is high following surgery for rectal cancer. Annals of Surgery 2005.26970Finkelstein JS. Increases in bone-density during treatment of men with idiopathic hypogonadotropic hypogonadism. Journal of Clinical Endocrinology & Metabolism 1989.26971Chang CS. Infertility with defective spermatogenesis and hypotestosteronemia in male mice lacking the androgen receptor in Sertoli cells. Proceedings of the National Academy of Sciences of the United States of America 2004.25872Wang C. Investigation, treatment and monitoring of late-onset hypogonadism in males. European Journal of Endocrinology 2008.25673Weiss J. Hypogonadism caused by a single amino-acid substitution in the beta subunit of luteinizing-hormone. New England Journal of Medicine 1992.25474Kaiser DR. Impaired brachial artery endothelium-dependent and -independent vasodilation in men with erectile dysfunction and no other clinical cardiovascular disease. Journal of the American College of Cardiology 2004.25375Ellenber M. Impotence in diabetes - neurologic factor. Annals of Internal Medicine 1971.24976Althof SE. EDITS: Development of questionnaires for evaluating satisfaction with treatments for erectile dysfunction. Urology 1999.24777Slag MF. Impotence in medical clinic outpatients. Journal of the American Medical Association 1983.24678Kapoor D. Clinical and biochemical assessment of hypogonadism in men with type 2 diabetes: Correlations with bioavailable testosterone and visceral adiposity. Diabetes Care 2007.24479Maden C. History of circumcision, medical conditions, and sexual-activity and risk of penile cancer. Journal of the National Cancer Institute 1993.24380Palermo GD. Intracytoplasmic sperm injection - a novel treatment for all forms of male factor infertility. Fertility and Sterility 1995.24281Woolf PD. Transient hypogonadotropic hypogonadism caused by critical illness. Journal of Clinical Endocrinology & Metabolism 1985.24282Ghofrani HA. Sildenafil: from angina to erectile dysfunction to pulmonary hypertension and beyond. Nature Reviews Drug Discovery 2006.24083Nicolosi A. Epidemiology of erectile dysfunction in four countries: Cross-national study of the prevalence and correlates of erectile dysfunction. Urology 2003.24084Bivalacqua TJ. RhoA/Rho-kinase suppresses endothelial nitric oxide synthase in the penis: A mechanism for diabetes-associated erectile dysfunction. Proceedings of the National Academy of Sciences of the United States of America 2004.23985de Kretser DM. Male infertility. Lancet 1997.23986Macleod J. The male factor in fertility and infertility .2. Spermatozoon counts in 1000 men of known fertility and in 1000 cases of infertile marriage. Journal of Urology 1951.23987Sharma RK. The reactive oxygen species - total antioxidant capacity score is a new measure of oxidative stress to predict male infertility. Human Reproduction 1999.23888McVary KT. Sildenafil citrate improves erectile function and urinary symptoms in men with erectile dysfunction and lower urinary tract symptoms associated with benign prostatic hyperplasia: A randomized, double-blind trial. Journal of Urology 2007.23589User HM. Penile weight and cell subtype specific changes in a post-radical prostatectomy model of erectile dysfunction. Journal of Urology 2003.23390Seminara SB. Gonadotropin-releasing hormone deficiency in the human Idiopathic hypogonadotropic hypogonadism and Kallmann's syndrome: Pathophysiological and genetic considerations. Endocrine Reviews 1998.23391Korenman SG. Secondary hypogonadism in older men - its relation to impotence. Journal of Clinical Endocrinology & Metabolism 1990.23192Talcott JA. Patient-reported impotence and incontinence after nerve-sparing radical prostatectomy. Journal of the National Cancer Institute 1997.22993Montague DK. American Urological Association guideline on the management of priapism. Journal of Urology 2003.22894Marks LS. Effect of testosterone replacement therapy on prostate tissue in men with late-onset hypogonadism - A randomized controlled trial. Journal of the American Medical Association 2006.22695Benet AE. The epidemiology of erectile dysfunction. Urologic Clinics of North America 1995.22596Sikka SC. Role of oxidative stress and antioxidants in male infertility. Journal of Andrology 1995.22597Balhorn R. Aberrant protamine-1 protamine-2 ratios in sperm of infertile human males. Experientia 1988.22598Daling JR. Penile cancer: importance of circumcision, human papillomavirus and smoking in in situ and invasive disease. International Journal of Cancer 2005.22499Cummins JM. Molecular-biology of human male-infertility - links with aging, mitochondrial genetics, and oxidative stress. Molecular Reproduction and Development 1994.224100Saleh RA. Negative effects of increased sperm DNA damage in relation to seminal oxidative stress in men with idiopathic and male factor infertility. Fertility and Sterility 2003.218

The 100 most cited manuscripts were published over a broad time period, with the greatest proportion between 2000 and 2009 (*n* = 41), as demonstrated in Fig. [1](#Fig1){ref-type="fig"}. The most historic article was that by Macleod and Gold reporting comparative semen analysis in both 'fertile' and 'infertile' men, published in The Journal of Urology in 1951 and cited 239 times \[[@CR14]\]. The most recent manuscript was that published in 2010 in European Urology by Hatzimouratidis, et al. outlining the European Association of Urology guidelines on investigation and management of male sexual dysfunction, which has been cited 420 times \[[@CR15]\].Fig. 1Bar graph demonstrating the distribution of the 100 most cited articles according to the decade in which they were published

Table [2](#Tab2){ref-type="table"} outlines the 43 journals in which the top 100 manuscripts were published. The Journal of Urology (impact factor 5.157) published the highest number (*n* = 11), including the most cited article by Feldman et al. \[[@CR13]\], and accrued a total overall citation number of 6771. This was followed by The New England Journal of Medicine, which published 10 manuscripts and was also the journal with the highest impact factor (72.406).Table 2Journals in which the 100 most cited manuscripts were published, ranked according to number with corresponding impact factors at the time of reviewJournal TitleImpact Factor as of 2016Number of Manuscripts in Top 100Total number of citationsJournal of Urology5.157116771New England Journal of Medicine72.406105388Journal of Clinical Endocrinology and Metabolism5.45582610Journal of the American Medical Association44.40563074Urology2.30953784Fertility and Sterility4.44741171Proceedings of the National Academy of Sciences of the United States of America9.66142127European Urology16.26531435Human Reproduction Update11.74831198International Journal of Impotence Research1.29332187Journal of Andrology2.47331142Lancet47.8313993Nature40.13731264Annals of Internal Medicine17.2022544Endocrinology4.2862898Human Reproduction5.022515Journal of the National Cancer Institute13.7572472American Journal of Medicine5.551276American Journal of Reproductive Immunology3.0131299Annals of Surgery8.981269Bioorganic & Medicinal Chemistry Letters2.4541421British Journal of Psychiatry6.3471374British Journal of Urology^a^1.691423British Journal of Urology International4.4391553British Medical Journal17.2151421Current Medical Research and Opinion2.7571297Diabetes Care11.8571244Diabetologia6.081287Endocrine Reviews15.7451233European Journal of Endocrinology4.1011256Experientia2.0721225Heart6.0591270International Journal of Cancer6.5131224International Journal of Clinical Practice2.141331Journal of the American College of Cardiology19.8961253Molecular Reproduction and Development2.3161224Nature Genetics27.9591395Nature Reviews Drug Discovery571240Preventive Medicine3.4341431Psychosomatic Medicine3.8631345Radiology7.2961298Science37.2051492Urologic Clinics of North America2.221225^a^Impact Factor available for 2000 only

The country with the greatest number of publications was the United States of America (*n* = 66), followed by the United Kingdom (*n* = 12) and Canada (*n* = 5). The Massachusetts General Hospital was the institution with the greatest number of manuscripts (*n* = 7), followed jointly by the Cleveland Clinic and New England Research Institute (n = 6 respectively), all of which are based in the USA. RC Rosen \[[@CR16]--[@CR19]\] and TF Lue \[[@CR20]--[@CR22]\] were the first authors with the highest number of manuscripts in the top 100, achieving 4 and 3 respectively. A number of senior authors published more than one manuscript, with JB McKinlay achieving the greatest (*n* = 5), including the most cited article \[[@CR13], [@CR23]--[@CR26]\].

Figure [2](#Fig2){ref-type="fig"} gives the top 100 manuscripts according to type. The majority were original research articles (*n* = 77, Fig. [2a](#Fig2){ref-type="fig"}), of which 59 (76.6%) reported clinical outcomes (based on either observational or interventional methodology) and 18 (23.4%) reported the findings of basic scientific work (Fig. [2b](#Fig2){ref-type="fig"}). The number of manuscripts pertaining to each of the main andrology themes are given in Fig. [3](#Fig3){ref-type="fig"}a. ED was the most common (*n* = 46), followed jointly by hypogonadism and male factor infertility (*n* = 24 respectively). Figure [3](#Fig3){ref-type="fig"}b demonstrates manuscript theme as strafitied by decade of publication. Hypogonadism was the most common theme prior to 1980 (n = 4), after which ED remained the most common up until 2010. Despite an overall trend of increasing numbers of manuscripts focussing on ED within the top 100 during this period, the relative proportion of manuscripts fell with each decade (66.7, 47.1 and 46.3% between 1980 and 89, 1990--99 and 2000--09 respectivelty).Fig. 2Manuscript type. **a** Bar graph demonstrating composition of the 100 most cited articles according to manuscript type. **b** Pie chart demonstrating the study design of the 77 original research articlesFig. 3Bar graph demonstrating composition of the 100 most cited articles according to theme. **a** overall. **b** stratified according to decade of publication

The citation rate of the top 10 manuscripts ranged from 118 to 45, as shown in Table [3](#Tab3){ref-type="table"}. A number of articles from the top 10 remained the same when ranked by citation rate, although three were replaced by the more contemporary manuscripts by Wu, et al. (2010, 524 citations) \[[@CR27]\], Hatzimouratidis, et al. (2010, 420 citations) \[[@CR15]\] and Tremellen (2008, 479 citations) \[[@CR28]\].Table 3Top 10 manuscripts with the highest citation rateRankCitation RateFirst AuthorSenior AuthorTitleFirst author institutionCountry1118Rosen RCMishra AThe international index of erectile function (IIEF): A multidimensional scale for assessment of erectile dysfunctionUniversity of Medicine and Dentistry of New JerseyUSA2117Feldman HAMcKinlay JBImpotence and its medical and psychosocial correlates - results of the Massachusetts male aging studyNew England Research InstituteUSA382de Roux NMilgrom EHypogonadotropic hypogonadism due to loss of function of the KiSS1-derived peptide receptor GPR54Hôpital de BicêtreFrance476Goldstein IWicker PAOral sildenafil in the treatment of erectile dysfunctionBoston University Medical CentreUSA570Rosen RCPena BMDevelopment and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunctionRobert Wood Johnson Medical SchoolUSA666Wu FCWHuhtaniemi ITIdentification of Late-Onset Hypogonadism in Middle-Aged and Elderly MenUniversity of ManchesterUK753Hatzimouratidis KWespes EGuidelines on Male Sexual Dysfunction: Erectile Dysfunction and Premature EjaculationAristotle University of ThessalonikiGreece851Droller MJHall WHImpotence: NIH consensus development panel on impotenceMount Sinai Medical CenterUSA948Tremellen KTremellen KOxidative stress and male infertility - a clinical perspectiveRepromed & University of AdelaideAustralia1045Rosen RCGiuliano FLower urinary tract symptoms and male sexual dysfunction: The multinational survey of the aging male (MSAM-7)Robert Wood Johnson Medical SchoolUSA

Discussion {#Sec4}
==========

This study is the first bibliometric analysis to identify and analyse the most influential manuscripts in the field of andrology. A range of topics were represented within the top 100, which reflects the spectrum of clinical andrological practice as well as the variation in the specialist backgrounds of andrological practitioners and researchers. Similarly, there is significant overlap with other medical specialties including, but not limited to, endocrinology. Despite this overlap, the most prevalent theme of publication was the assessment and/or treatment of patients with ED, constituting 46 papers within the top 100. This included the most cited article by Feldman, et al. \[[@CR13]\] describing the prevalence of, and risk factors for, ED in the Massachusetts Male Ageing Study, published in The Journal of Urology in 1994 and cited 2819 times. The Massachusetts Male Aging Study was a community-based, observational survey of non-institutionalised men between 40 and 70 years old conducted between 1987 to 1989 in cities and towns near Boston, Massachusetts. The aim was to correlate a self-administered erectile function questionnaire with an assessment of patients' overall health. The authors noted a strong correlation with patients who had vascular, cardiac or smoking-related diseases and concluded that ED was associated with potentially reversible age-related changes.

The self-administered erectile function questionnaire reported in the Feldman, et al. study differed from the now more commonly used International Index of Erectile Function (IIEF), which was first described three years later in 1997 by Rosen, et al. \[[@CR16]\]. This landmark publication constituted the second most cited article in this bibliometric analysis. Similarly, the fourth most cited article described an updated version of the IIEF questionnaire and was again published by Rosen, et al. \[[@CR17]\]. The reason that these papers have been cited so frequently is most likely due to both the high overall prevalence of publications focussing on ED, and the fact that the IIEF-5 is widely used in clinical practice to measure the severity of ED and is hence frequently used in research studies as an 'objective' measurement of function, treatment efficacy or response.

Fourteen manuscripts in the top 100 focussed specifically on the treatment of ED. These ranged in age from the article by Brindley in 1983 examining the effects of intra-cavernosal alpha-blockade \[[@CR29]\], to that by McVary, et al. in 2007 reporting the results of a randomised controlled trial investigating the effects of oral sildenafil on both ED and urinary symptoms \[[@CR30]\]. This analysis demonstrates that there was a significant increase in the number of influential manuscripts focussing on the treatment of ED following publication of the landmark paper by Goldstein, et al. in 1998 reporting the effectiveness of oral sildenafil \[[@CR31]\]. This was the first paper to describe an oral treatment for ED and is the third most cited manuscript in the top 100. Prior to this time, treatments had been relatively intolerable for patients, including vacuum tumescence devices, intracavernosal injections of vasoactive agents, transurethral delivery of alprostadil, and invasive surgical procedures. The availability of oral treatments for ED subsequently resulted in a rapid increase in research being undertaken into all aspects of the condition, which is reflected in the numerous manuscripts published after 1998 that feature in the top 100 (Figs. [1](#Fig1){ref-type="fig"} and [3](#Fig3){ref-type="fig"}b). Furthermore, it is probable that there was an increase in self-reporting of ED and a drive towards increased research funding and activity when a number of 'tolerable' treatments became available.

A significant majority of manuscripts were published by authors in the United States of America (*n* = 66), followed by the United Kingdom (*n* = 12) and Canada (*n* = 5). This disparity between the USA and other countries may reflect the subspecialisation that occurs in contemporary American Urological practice compared with other geographical regions \[[@CR32]\]. This means that clinicians are more likely to be solely practicing andrology, with less emphasis on provision of 'core urological' services, therefore potentially allowing more time for academic pursuits. This geographical dominance has also been observed in other bibliometric analyses \[[@CR7]\] and may also be explained by differences in academic focus in relation to clinical practice, with more funding provided to clinicians' academic work in the USA compared to elsewhere, which in turn appears to correlate with a higher quality of research \[[@CR33]\].

It is important to note that only two manuscripts within the top 100 focus on the management of penile cancer (Maden, ranked 79 \[[@CR34]\] and Daling, ranked 98 \[[@CR35]\]). This is the only cancer that is commonly managed by andrologists and therefore one would expect to see a greater number of manuscripts related to its pathophysiology, treatment and follow-up within the top 100. However, it is likely that the low incidence of this condition makes it a relative 'Cinderella' subspecialty within the field and therefore papers focussed on penile cancer are less widely cited when compared to the much more commonly encountered conditions of ED and hypogonadism \[[@CR36]\]. Moreover, due to the paucity of cases seen in routine practice it is difficult to establish a cohort of sufficient size for high quality observational or interventional research. This, coupled with the known difficulties in conducting high quality surgical trials \[[@CR37]\], means that manuscripts are often of low levels of evidence, thus precluding them from publication in high impact factor journals.

The journals in which the top 100 manuscripts were published varied significantly both in theme and impact factor. The latter was particularly varied and ranged from 72.406 to 1.293 (median 5.5025). Interestingly, impact factor did not necessarily correlate with the most cited papers. For example, the second most cited paper by Rosen, et al. \[[@CR16]\] was published in 'Urology', which was the sixth-lowest ranked journal in terms of impact factor within this analysis (2.309). One explanation for this variation is the multidisciplinary nature of many conditions encountered under the umbrella of andrology. Furthermore, the subspecialised nature of many andrological conditions means that manuscripts pertaining to these topics are often not directly relevant to 'core' clinical practice and are therefore less likely to be published in higher impact factor journals that seek to meet the interests of a broad audience.

The main limitation of bibliometric analysis is the potential for a number of types of bias. Firstly, disproportionate citation may result from institutional bias, language biases, self-citation or powerful person bias. In addition, older manuscripts may receive more citations due to the length of time in which they are in the public domain. Although the use of citation rate attempts to control for this, it may take a number of years for influential manuscripts to accrue citations due to the publication lead-time for their citing manuscript. A further limitation is the inclusion of only first and senior authors, and the institution of the first author. It is possible that several first authors will have co-authored other papers in the top 100 and therefore be underrepresented in the current study. Finally, searching based on title means a small number of manuscripts that have key andrological themes without pertaining to these in their title may not have been identified.

Conclusion {#Sec5}
==========

This list of highly cited papers identifies the topics and authors that have made the most impact in the discipline of andrology over the last century. There is a clear predominance of manuscripts focusing on the treatment and pathophysiology of ED, which should therefore be considered the most widely researched, published and cited field within andrological practice. This study provides a reference of what may be considered as the most influential papers in andrology and serves as a inidcation of what comprises a 'highly citable' manuscript for both researchers and clinicians.
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